EBOS Group Limited
EBOSYOTCHealthcare● Active
$24.13
$-1.87(-7.19%)
Market Cap$1.2B
P/E Ratio—
52W High$46.64
52W Low$24.13
EBOS Group Limited（EBOSY）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · EBOSY · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.00B | $0.27B | $0.28B | $0.07B | $0.07B |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.09B | $0.07B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | $0.00B | ($0.06B) | ($0.03B) | $0.00B | $0.07B |
| Net Cash from Operations | $0.42B | $0.34B | $0.40B | $0.26B | $0.30B |
| Investing Activities | |||||
| Capital Expenditure | ($0.05B) | ($0.09B) | ($0.11B) | ($0.10B) | ($0.09B) |
| Purchases of Investments | ($0.02B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.00B) |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Net Cash from Investing | ($0.37B) | ($0.37B) | ($0.16B) | ($1.47B) | ($0.11B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($0.14B) | ($0.16B) | ($0.18B) | ($0.17B) | ($0.13B) |
| Debt Issued / Repaid | ($0.14B) | $0.26B | ($0.40B) | $1.00B | ($0.13B) |
| Net Cash from Financing | ($0.08B) | $0.03B | ($0.55B) | $1.58B | ($0.26B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.37B | $0.25B | $0.32B | $0.18B | $0.23B |
| FCF Margin %(computed) | 3.00% | 1.88% | 2.60% | 1.48% | 2.52% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · AUD · B
深入了解EBOS Group Limited
关于EBOS Group Limited（EBOSY）现金流量表
EBOS Group Limited 2025财年经营活动现金流$0.42B，自由现金流$0.37B（FCF利润率3.00%），资本支出($0.05B)。
常见问题
EBOSY · 4 问EBOS Group Limited 2025财年自由现金流$0.37B，同比up47.8%。
EBOSY free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10